| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78cf78520cbd0bd762e19b5f48e64220 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1992-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8abbb9f3d5d20fb778f137f8db05d42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ae24eb2cce17d9d48da4415e6748895 |
| publicationDate |
1994-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H06183963-A |
| titleOfInvention |
Tyrosine-specific kinase inhibitor and anticancer agent |
| abstract |
(57) [Summary] [Structure] A tyrosine-specific phosphatase inhibitor containing a sulfated tyrosine or a physiologically acceptable salt thereof as an active ingredient, and an anticancer agent. [Effect] It has low toxicity, and has a remarkable tyrosine-specific phosphatase inhibitory activity and a carcinostatic effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020194563-A1 |
| priorityDate |
1992-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |